These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [New aspects in the management of exudative age-related macular degeneration - current position of the Retinological Society, the German Ophthalmology Society and the Professional Union of Ophthalmologists in Germany]. Klin Monbl Augenheilkd; 2009 May; 226(5):388-95. PubMed ID: 19507085 [TBL] [Abstract][Full Text] [Related]
8. Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration. Shah AR; Del Priore LV Ophthalmology; 2009 Oct; 116(10):1901-7. PubMed ID: 19592101 [TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts. Noël A; Jost M; Lambert V; Lecomte J; Rakic JM Trends Mol Med; 2007 Aug; 13(8):345-52. PubMed ID: 17644433 [TBL] [Abstract][Full Text] [Related]
16. Subfoveal exudative age-related macular degeneration: evidence for preoccult disease. Shah AR; Del Priore LV Curr Opin Ophthalmol; 2009 May; 20(3):182-7. PubMed ID: 19367162 [TBL] [Abstract][Full Text] [Related]
17. Early clinical experience with ranibizumab for occult and minimally classic neovascular membranes in age-related macular degeneration. Mantel I; Zografos L; Ambresin A Ophthalmologica; 2008; 222(5):321-3. PubMed ID: 18617755 [TBL] [Abstract][Full Text] [Related]
18. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration. Arias L; Ruiz-Moreno JM; Gómez-Ulla F; Fernández M; Montero J Retina; 2009; 29(10):1444-9. PubMed ID: 19730163 [TBL] [Abstract][Full Text] [Related]
19. Leucine 7-proline 7 polymorphism in the signal peptide of neuropeptide Y is not a risk factor for exudative age-related macular degeneration. Kaarniranta K; Holopainen JM; Karvonen MK; Koulu M; Kallio J; Pesonen U; Teräsvirta M; Uusitalo H; Immonen I Acta Ophthalmol Scand; 2007 Mar; 85(2):188-91. PubMed ID: 17305733 [TBL] [Abstract][Full Text] [Related]
20. Comparison of spectral-domain versus time-domain optical coherence tomography in management of age-related macular degeneration with ranibizumab. Sayanagi K; Sharma S; Yamamoto T; Kaiser PK Ophthalmology; 2009 May; 116(5):947-55. PubMed ID: 19232732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]